In fact, a similar transient discrepancy between bone marrow iron availability and requirements during increased erythropoietic activity is observed despite the use of oral iron supplements in chronic dialysis patients and healthy individuals who received EPO treatment for anemia [36]. This evidence concerns the gene EPO and anemia (phenotype).